Institutional Ownership
Cogent Biosciences Inc
CUSIP 19240Q201COMCOGTQ1 2026
13D / 13G Filings
83
Schedule 13D/13G on record
Beneficial Filers
29
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
297
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
83 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Kynam Capital Management, LP | 13G/A | 4.3% | 6.17M | SEC |
| 2 | Feb 17, 2026 | Commodore Capital LP | 13G/A | 11.0% | 2.80M | SEC |
| 3 | Jan 30, 2026 | The Vanguard Group | 13G/A | 7.5% | 11.51M | SEC |
| 4 | Jan 22, 2026 | Fairmount Funds Management LLC | 13D/A | 9.9% | — | SEC |
| 5 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 6.5% | 11.37M | SEC |
| 6 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 6.5% | 11.37M | SEC |
| 7 | Nov 17, 2025 | Fairmount Funds Management LLC | 13D/A | 9.9% | — | SEC |
| 8 | Nov 14, 2025 | Kynam Capital Management, LP | 13G/A | 5.5% | 7.89M | SEC |
| 9 | Nov 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 10.21M | SEC |
| 10 | Nov 14, 2025 | Tcg Crossover Gp I, LLC | 13G/A | 11.0% | 6.80M | SEC |
73 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cogent Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 23.12M | $889.99M |
| 2 | Blackrock, Inc. | 16.05M | $617.57M |
| 3 | Deerfield Management Company, L.P. | 9.04M | $348.10M |
| 4 | Janus Henderson Group PLC | 5.97M | $229.63M |
| 5 | State Street Corp | 5.66M | $217.99M |
| 6 | Fairmount Funds Management LLC | 5.50M | $211.83M |
| 7 | Rtw Investments, LP | 5.46M | $210.10M |
| 8 | Tcg Crossover Management, LLC | 4.95M | $190.41M |
| 9 | Goldman Sachs Group Inc | 4.43M | $170.67M |
| 10 | Kynam Capital Management, LP | 4.04M | $155.40M |